Went public 12/07/00 at $8 per share.
Filing Range: 6.42 million shares @ $9 to $10
Shares Outstanding: 24.78 million shares
Underwriters: Thomas Weisel Partners LLC/Dain Rauscher
Company Counsel: Goodwin Procter & Hoar
Manager Counsel: Mintz Levin Cohn Ferris Glovsky & Popeo
Auditor: KPMG LLP
Distributes and sells medical devices through catalogs and the Internet. The company’s products include volume and pressure controlled ventilators, pulsatile blood pumps, transducers, amplifiers, recorders, glassware and many other specialized bioscience research products.
New England Partners
Ascent Venture Partners
First New England Capital LP
Number of Round Amt.
Round # Round Date Stage Investors ($ thousands)
1 03/01/1996 2 Early Stage 990.0
2 05/11/1999 2 Expansion 1038.0
(Data in $ millions)
Total Revenues: $26.2
Net Income: (29.4)